BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
-15.32%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$1.26B
AUM Growth
+$1.26B
(-18%)
Cap. Flow
-$28.8M
Cap. Flow
% of AUM
-2.29%
Top 10 Holdings %
Top 10 Hldgs %
45.22%
Holding
99
New
8
Increased
29
Reduced
26
Closed
14
Top Buys
Top Sells
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$130M |
| 2 |
Assertio
ASRT
|
$25.1M |
| 3 |
ALR
Alere Inc
ALR
|
$23.9M |
| 4 |
Heron Therapeutics
HRTX
|
$13M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$9.47M |
Sector Composition
| 1 | Healthcare | 90.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $132M | 7.35% | 6,665,391 +1,849,584 | +38% | +$36.7M |
|
|
NVRO
2
DELISTED
NEVRO CORP.
NVRO
| $74.6M | 4.15% | 1,607,085 +1,187,526 | +283% | +$55.1M |
|
|
AVDL
3
Avadel Pharmaceuticals
AVDL
$1.43B
| $71.7M | 3.99% | 4,394,464 -580,720 | -12% | -$9.47M |
|
4
Travere Therapeutics
TVTX
$1.56B
| $52.9M | 2.94% | 2,609,790 +446,862 | +21% | +$9.05M |
|
|
PGNX
5
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $51.2M | 2.85% | 8,951,169 | – | – |
|
6
Emergent Biosolutions
EBS
$443M
| $46.2M | 2.57% | 1,621,832 -138,687 | -8% | -$3.95M |
|
|
7
Heron Therapeutics
HRTX
$207M
| $45.4M | 2.53% | 1,862,001 -534,680 | -22% | -$13M |
|
8
AngioDynamics
ANGO
$417M
| $31.6M | 1.76% | 2,398,527 | – | – |
|
|
AEGR
9
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $31.6M | 1.76% | 2,320,366 -532,212 | -19% | -$7.24M |
|
|
LJPC
10
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $30.4M | 1.69% | 1,095,373 +335,903 | +44% | +$9.33M |
|
|
BDSI
11
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $26.4M | 1.47% | 4,744,060 +1,200,000 | +34% | +$6.67M |
|
|
SCTL
12
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $24.8M | 1.38% | 2,060,086 +646,553 | +46% | +$7.78M |
|
|
NVDQ
13
DELISTED
Novadaq Technologies Inc.
NVDQ
| $19.9M | 1.11% | 1,908,648 +1,384,785 | +264% | +$14.4M |
|
|
RXDX
14
DELISTED
Ignyta, Inc.
RXDX
| $19.8M | 1.1% | 2,256,546 | – | – |
|
15
Dynavax Technologies
DVAX
$1.19B
| $19.4M | 1.08% | 789,710 +23,700 | +3% | +$582K |
|
|
PTX
16
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $19.2M | 1.07% | 6,090,829 +1,014,900 | +20% | +$3.21M |
|
|
CSII
17
DELISTED
Cardiovascular Systems, Inc.
CSII
| $19M | 1.06% | +1,200,000 | New | +$19M |
|
|
ADXS
18
DELISTED
Advaxis, Inc.
ADXS
| $17.8M | 0.99% | 1,736,834 +286,740 | +20% | +$2.93M |
|
|
ACGN
19
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $17.5M | 0.97% | 5,213,979 -449,866 | -8% | -$1.51M |
|
|
CORI
20
DELISTED
Corium International, Inc.
CORI
| $16.9M | 0.94% | 1,802,092 +297,330 | +20% | +$2.78M |
|
21
Masimo
MASI
$7.59B
| $16.3M | 0.9% | +421,728 | New | +$16.3M |
|
|
SPNE
22
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $16.2M | 0.9% | +1,000,007 | New | +$16.2M |
|
23
Zevra Therapeutics
ZVRA
$509M
| $15.5M | 0.86% | 799,788 -28,022 | -3% | -$543K |
|
|
SPPI
24
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $15.1M | 0.84% | 2,516,748 -133,252 | -5% | -$797K |
|
|
TLGT
25
DELISTED
Teligent, Inc
TLGT
| $15M | 0.83% | 2,287,728 | – | – |
|